Team:Peking R/HumanPractice/Investigation2

From 2011.igem.org

(Difference between revisions)

Latest revision as of 07:23, 5 October 2011

Template:Https://2011.igem.org/Team:Peking R/bannerhidden Template:Https://2011.igem.org/Team:Peking R/back2 Template:Https://2011.igem.org/Team:Peking R/Humanpracticebackground 无标题文档

Investigation of Antibiotic Use and

Related Biosafety Issues: What's

happening out there and further.

Question 5

B.Usually discard directly and occasionally process them properly(22.73%)

C.Usually process them properly but occasionally discard directly(21.59%)

D.Always properly process them separately with other waste(23.86%)

E.No special attention has been paid(15.91%)

Question 6

Question 8

Question 9

Prev	1	2	3	Next

Prev	1	2	3	Next

@@ Line 19: / Line 19: @@
 	color: #333;
 	text-align: justify;
-	background-color: #E9FEF0;
+	background-color: #FFF;
 }
 .notbookmaintitle {
@@ Line 109: / Line 109: @@
 .clickteam {
 	color: #000;
+	text-align: center;
 }
 a:link {
@@ Line 133: / Line 134: @@
 	height:1725px;
 	z-index:3;
-	text-align: justify;
+	text-align: left;
 	color: #000;
+	font-family: Georgia, "Times New Roman", Times, serif;
 }
 .mainbody {
@@ Line 254: / Line 256: @@
 <div id="apDiv4">
    <p><br />
-   <span class="clickteam">Question 5</span></p>
+   <span class="clickteam">Question 5</span>  </p>
-   <p class="clickteam"><img src="https://static.igem.org/mediawiki/2011/7/73/PekingR_hp_Q5.png" width="500" height="426" hspace="50" /></p>
+   <p class="clickteam"><img src="https://static.igem.org/mediawiki/2011/7/73/PekingR_hp_Q5.png" width="386" height="290" hspace="50" /></p>
-   <table border="0" cellspacing="0" cellpadding="0" width="521">
+   <p>&nbsp;
-    <tr>
+</p>
-      <td width="521" nowrap="nowrap" bgcolor="#E9FEF0" class="clickteam">        A.Almost    always discard directly or pour into sewage(15.91%) </td>
+        <p>
-    </tr>
+       B.Usually discard directly and occasionally process them properly(22.73%)</p>
-    <tr>
+       <p>C.Usually process them properly but occasionally discard directly(21.59%)</p>
-       <td width="521" nowrap="nowrap" bgcolor="#E9FEF0"><p align="left" class="clickteam">B.Usually    discard directly and occasionally process them properly(22.73%)</p></td>
+ <p>     D.Always properly process them separately with other waste(23.86%)</p>
-    </tr>
+     <p>  E.No special attention has been paid(15.91%)</p>
-    <tr>
+     <p>&nbsp;</p>
-       <td width="521" nowrap="nowrap" bgcolor="#E9FEF0"><p align="left" class="clickteam">C.Usually    process them properly but occasionally discard directly(21.59%)</p></td>
-    </tr>
-     <tr>
-      <td width="521" nowrap="nowrap" bgcolor="#E9FEF0"><p align="left" class="clickteam">D.Always    properly process them separately with other waste(23.86%)</p></td>
-     </tr>
-    <tr>
-      <td width="521" nowrap="nowrap" bgcolor="#E9FEF0"><p align="left" class="clickteam">E.No    special attention has been paid(15.91%)</p></td>
-     </tr>
-   </table>
    <p class="clickteam">Question 6</p>
-   <p class="clickteam"><img src="https://static.igem.org/mediawiki/2011/f/fd/PekingR_hp_Q6.png" width="500" height="253" hspace="50" /><br />
+   <p class="clickteam"><img src="https://static.igem.org/mediawiki/2011/f/fd/PekingR_hp_Q6.png" width="476" height="239" hspace="50" /><br />
      <br />
      Question 8</p>
    <p class="clickteam"><img src="https://static.igem.org/mediawiki/2011/7/7c/PekingR_hp_Q8.png" width="500" height="360" hspace="50" /></p>
-   <p>Question 9</p>
+   <p class="clickteam">Question 9</p>
-   <p><img src="https://static.igem.org/mediawiki/2011/c/ca/PekingR_hp_Q9.png" alt="" width="600" height="394" /><br />
+   <p><img src="https://static.igem.org/mediawiki/2011/c/ca/PekingR_hp_Q9.png" alt="" width="500" height="328" hspace="50" /></p>
-    <br />
+  <p>&nbsp;</p>
-    In the final part of our survey, we  try to look at the attitudes towards possible approaches to ensure biosafety  related to ARB. Most respondents chose to employ proper procedures for  processing used microbes in the laboratory rather than use special plasmids  that minimize HGT(Q12). This is in fact a more rational choice as adopting  special plasmids may lower researchers’ awareness of HGT and give rise to new  threats. As to whether the government should implement new policies to regulate  the processing of used ARB, most agreed, but some showed opposition(Q13)  contending that it might be troublesome in determining the details and that  still it would be difficult to make the policies work: the government is  unlikely supervise the treatment of RAB every minute. Besides, we also wander  whether the government will run the risk of impeding research progress by heavily  punishing laboratories for violating these policies.</p>
    <p>&nbsp;</p>
    <hr />
@@ Line 294: / Line 287: @@
        <th width="31" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th>
        <th width="16" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th>
-       <th width="18" bgcolor="#E9FEF0" class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">2</a></th>
+       <th width="18" bgcolor="#CCCCCC" class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">2</a></th>
        <th width="15" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th>
        <th width="45" bgcolor="#E9FEF0"class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">Next</a></th>
@@ Line 305: / Line 298: @@
        <th width="42" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th>
        <th width="17" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th>
-       <th width="16" bgcolor="#E9FEF0" class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">2</a></th>
+       <th width="16" bgcolor="#CCCCCC" class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">2</a></th>
        <th width="18" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th>
        <th width="44" bgcolor="#E9FEF0"class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">Next</a></th>